Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Aurothiopropanosulfonate

3

IV.c Obliterative bronchiolitis (a pattern consistent with) (see also IVn, XVx)

1
Last update : 07/07/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Gold (chrysotherapy)
3

Publications

Bronchiolar disease associated with gold compounds administration in a patient with rheumatoid arthritis.
Modern rheumatology 2005;15;148-52 2005
Gold-induced pulmonary disease: clinical features, outcome, and differentiation from rheumatoid lung disease.
American journal of respiratory and critical care medicine 1997 Mar;155;1011-20 1997 Mar
Constrictive bronchiolitis obliterans following gold therapy for psoriatic arthritis.
The European respiratory journal 1995 Dec;8;2191-3 1995 Dec

Powered by

  • ^
  • Contact
  • Cookies
  • About